Genetically engineered T cells for cancer immunotherapy
2019 · Signal Transduction and Targeted Therapy · 238 citations
https://doi.org/10.1038/s41392-019-0070-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
1.7K
Citations
20
h-index
35
i10-index
Weilin Zhou is an academic researcher from Sichuan University. The author has contributed to research in topics: CAR-T cell therapy research & Conducting polymers and applications & Pulmonary Hypertension Research and Treatments. The author has an h-index of 20, co-authored 63 publications.
ORCID: 0009-0009-2615-6306https://doi.org/10.1038/s41392-019-0070-9
https://doi.org/10.1038/s41598-025-95067-x
https://doi.org/10.1016/j.joule.2025.102299
Click to start Chat